Screener
DENTSPLY SIRONA XRAY Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 49.5%-2.2pp | 48.9%-2.6pp | 50%-1.6pp | 50.9%-1.3pp | 51.7%-0.5pp | |
| Operating margin | -8.5%+19.7pp | -14.1%+8.9pp | -11.5%+11.7pp | -21.9%— | -28.2%— | |
| Net margin | -15%+10.9pp | -17.1%+7.4pp | -16.3%+7.7pp | -24.3%— | -25.9%— | |
| Returns | ||||||
| Return on equity | -33%+4.8pp | -37.7%-3.3pp | -36.5%-1.7pp | -44.4%— | -37.8%— | |
| Return on invested capital | -8.2%+14.5pp | -13.9%+4.8pp | -11.4%+7.7pp | -19.5%— | -22.8%— | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.7×+0.1× | 0.7×+0.1× | 0.6×0.0× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.6×-0.1× | 1.5×+0.4× | 1.5×+0.4× | 1.5×+0.2× | 1.7×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 1.7×+0.4× | 1.8×+0.6× | 1.8×+0.7× | 1.7×+0.7× | 1.3×+0.6× | |
| Net debt / EBITDA | 53.2×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $6.74-31.5% | $6.59-34.5% | $6.72-29.7% | $7.41-40.2% | $9.83-34.0% | |
| Valuation | ||||||
| Market capitalization | $2.64B-3.2% | $2.32B-22.1% | $2.28B-39.5% | $2.53B-54.5% | $3.12B-39.1% | |
| Price / sales | 0.7×0.0× | 0.6×-0.2× | 0.6×-0.4× | 0.7×-0.7× | 0.8×-0.5× | |
| Price / book | 2×+0.6× | 1.8×+0.3× | 1.7×-0.2× | 1.7×-0.5× | 1.6×-0.1× | |
| EV / EBITDA | 120.8×— | —— | —— | —— | —— |
FAQ
- What are DENTSPLY SIRONA's profit margins?
- DENTSPLY SIRONA (XRAY) runs a 49.5% gross margin and a -8.5% operating margin, with a -15.0% net margin.
- Where do DENTSPLY SIRONA's ratios come from?
- Every ratio is computed from DENTSPLY SIRONA's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
